Jooske Marije Funke Boomsma
Jooske Marije Funke Boomsma has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Anna E. Leeuwis
Elsevier, Journal Returns, 1799 Highway 50 East, Linn
2 shared publicationsFrederik Barkhof
Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands
2 shared publicationsGeert Jan Biessels
Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht Universiteit, Utrecht, the Netherlands
2 shared publications- Lieza Geertje Exalto
Alzheimer Center Department of Neurology Amsterdam Neuroscience Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam The Netherlands
2 shared publications - Niels Daniël Prins
Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands
2 shared publications Philip Scheltens
Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 1 June 2022
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 30 (7) , A2-A3
Table of Contents
- 1 June 2022
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 30 (7) , A2-A3
Open AccessTable of Contents
- Open Access
- 26 March 2022
- Published by Elsevier in Cerebral Circulation - Cognition and Behavior
- Vol. 3, 100141
Vascular Cognitive Impairment and cognitive decline; a longitudinal study comparing different types of vascular brain injury - The TRACE-VCI study
- 26 March 2022
- Published by Elsevier in Cerebral Circulation - Cognition and Behavior
- Vol. 3, 100141
Open AccessVascular Cognitive Impairment and cognitive decline; a longitudinal study comparing different types of vascular brain injury - The TRACE-VCI study
- 31 December 2021
- Published by Wiley in Alzheimer's & Dementia
- Vol. 17 (S6) , e052331
Cognitive decline in possible vascular cognitive impairment (VCI): Does the form of vascular brain injury matter?
Background: Patients presenting at a memory clinic with possible VCI include a heterogeneous population in terms of cognitive profile, vascular brain injury and prognosis. Little is known about the trajectories of cognitive decline on cognitive test performance in relation to the different forms of vascular brain injury.Method: We included 474 memory clinic patients(age 68(±8.2) years, 44% female, mean MMSE 25.9(±2.9), 212(44.7%) patients with dementia) from the prospective TRACE‐VCI cohort study with possible VCI; cognitive complaints and vascular brain injury on MRI. We assessed cognitive functioning at baseline and follow‐up(mean follow‐up time 2.5(±1.4) years, total of 1176 neuropsychological tests) including the Rey Auditory Verbal Learning Test(RAVLT) immediate and delayed recall(memory), the Trail Making Test(TMT) A and B(attention and executive functioning, respectively), category fluency(language) and MMSE. Linear mixed models were used to evaluate the effect of different forms of vascular brain injury on cognitive decline. Models included(dichotomized) terms for vascular brain injury(infarct(s), lacune(s), white matter hyperintensities(WMH), microbleed(s)), time and vascular brain injury*time. All models were adjusted for sex, age, diagnosis (dementia versus no dementia), education and medial temporal lobe atrophy(MTA) score(dichotomized as ≥1.5). Also, the models were evaluated in patients with a positive(+CSF‐AD) and negative(‐CSF‐AD) biomarker CSF Alzheimer profile.Result: Vascular brain injury(multiple forms in one patient possible) consisted of infarct(s) in 54(11.4%), lacune(s) in 108(22.8%), moderate/severe WMH in 212(44.7%) and microbleed(s) in 203(42.8%) patients. In 164(54.3%) patients the MTA score was ≥1.5. We found no association between any form of vascular brain injury and baseline cognition. Infarct(s) showed an association with worsening on the TMTB(β;30.19,p=.00), especially in patients with a –CSF‐AD(β;65.93,p=.00). This effect was not found in patients with a +CSF‐AD(β;‐25.24,p=.18). Lacune(s) were associated with a rate of decline in immediate memory(β;1.62), delayed recall(β;.33), category fluency(β;.44) and MMSE(β;.46;all p<0.05). Infarct(s) were associated with a slower rate of decline on category fluency(β;.96,p=.01). We found no association between WMH, microbleed(s) and rate of cognitive decline.Conclusion: In patients with possible VCI, infarct(s) were associated with steeper decline in executive functioning, especially in patients with a –CSF‐AD. Counterintuitively, the presence of lacune(s) and infarct(s) predisposed for a more favorable trajectory in memory.
- 31 December 2021
- Published by Wiley in Alzheimer's & Dementia
- Vol. 17 (S6) , e052331
Cognitive decline in possible vascular cognitive impairment (VCI): Does the form of vascular brain injury matter?
Background: Patients presenting at a memory clinic with possible VCI include a heterogeneous population in terms of cognitive profile, vascular brain injury and prognosis. Little is known about the trajectories of cognitive decline on cognitive test performance in relation to the different forms of vascular brain injury.Method: We included 474 memory clinic patients(age 68(±8.2) years, 44% female, mean MMSE 25.9(±2.9), 212(44.7%) patients with dementia) from the prospective TRACE‐VCI cohort study with possible VCI; cognitive complaints and vascular brain injury on MRI. We assessed cognitive functioning at baseline and follow‐up(mean follow‐up time 2.5(±1.4) years, total of 1176 neuropsychological tests) including the Rey Auditory Verbal Learning Test(RAVLT) immediate and delayed recall(memory), the Trail Making Test(TMT) A and B(attention and executive functioning, respectively), category fluency(language) and MMSE. Linear mixed models were used to evaluate the effect of different forms of vascular brain injury on cognitive decline. Models included(dichotomized) terms for vascular brain injury(infarct(s), lacune(s), white matter hyperintensities(WMH), microbleed(s)), time and vascular brain injury*time. All models were adjusted for sex, age, diagnosis (dementia versus no dementia), education and medial temporal lobe atrophy(MTA) score(dichotomized as ≥1.5). Also, the models were evaluated in patients with a positive(+CSF‐AD) and negative(‐CSF‐AD) biomarker CSF Alzheimer profile.Result: Vascular brain injury(multiple forms in one patient possible) consisted of infarct(s) in 54(11.4%), lacune(s) in 108(22.8%), moderate/severe WMH in 212(44.7%) and microbleed(s) in 203(42.8%) patients. In 164(54.3%) patients the MTA score was ≥1.5. We found no association between any form of vascular brain injury and baseline cognition. Infarct(s) showed an association with worsening on the TMTB(β;30.19,p=.00), especially in patients with a –CSF‐AD(β;65.93,p=.00). This effect was not found in patients with a +CSF‐AD(β;‐25.24,p=.18). Lacune(s) were associated with a rate of decline in immediate memory(β;1.62), delayed recall(β;.33), category fluency(β;.44) and MMSE(β;.46;all p<0.05). Infarct(s) were associated with a slower rate of decline on category fluency(β;.96,p=.01). We found no association between WMH, microbleed(s) and rate of cognitive decline.Conclusion: In patients with possible VCI, infarct(s) were associated with steeper decline in executive functioning, especially in patients with a –CSF‐AD. Counterintuitively, the presence of lacune(s) and infarct(s) predisposed for a more favorable trajectory in memory.
- Open Access
- 19 April 2017
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 6 (4) , e60
Vascular Cognitive Impairment in a Memory Clinic Population: Rationale and Design of the “Utrecht-Amsterdam Clinical Features and Prognosis in Vascular Cognitive Impairment” (TRACE-VCI) Study
Vascular Cognitive Impairment (VCI) refers to cognitive dysfunction due to vascular brain injury, as a single cause or in combination with other, often neurodegenerative, etiologies. VCI is a broad construct that captures a heterogeneous patient population both in terms of cognitive and noncognitive symptoms and in terms of etiology and prognosis. This provides a challenge when applying this construct in clinical practice. This paper presents the rationale and design of the TRACE-VCI study, which investigates the clinical features and prognosis of VCI in a memory clinic setting. The TRACE-VCI project is an observational, prospective cohort study of 861 consecutive memory clinic patients with possible VCI. Between 2009 and 2013, patients were recruited through the Amsterdam Dementia Cohort of the VU University Medical Centre (VUMC) (N=665) and the outpatient memory clinic and VCI cohort of the University Medical Centre Utrecht (UMCU) (N=196). We included all patients attending the clinics with magnetic resonance imaging (MRI) evidence of vascular brain injury. Patients with a primary etiology other than vascular brain injury or neurodegeneration were excluded. Patients underwent an extensive 1-day memory clinic evaluation including an interview, physical and neurological examination, assessment of biomarkers (including those for Alzheimer-type pathologies), extensive neuropsychological testing, and an MRI scan of the brain. For prognostic analyses, the composite primary outcome measure was defined as accelerated cognitive decline (change of clinical dementia rating ≥1 or institutionalization) or (recurrent) major vascular events or death over the course of 2 years. The mean age at baseline was 67.7 (SD 8.5) years and 46.3% of patients (399/861) were female. At baseline, the median Clinical Dementia Rating was 0.5 (interquartile range [IQR] 0.5-1.0) and the median Mini-Mental State Examination score was 25 (IQR 22-28). The clinical diagnosis at baseline was dementia in 52.4% of patients (451/861), mild cognitive impairment in 24.6% (212/861), and no objective cognitive impairment in the remaining 23.0% (198/861). The TRACE-VCI study represents a large cohort of well-characterized patients with VCI in a memory clinic setting. Data processing and collection for follow-up are currently being completed. The TRACE-VCI study will provide insight into the clinical features of memory clinic patients that meet VCI criteria and establish key prognostic factors for further cognitive decline and (recurrent) major vascular events.
- 19 April 2017
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 6 (4) , e60
Open AccessVascular Cognitive Impairment in a Memory Clinic Population: Rationale and Design of the “Utrecht-Amsterdam Clinical Features and Prognosis in Vascular Cognitive Impairment” (TRACE-VCI) Study
Vascular Cognitive Impairment (VCI) refers to cognitive dysfunction due to vascular brain injury, as a single cause or in combination with other, often neurodegenerative, etiologies. VCI is a broad construct that captures a heterogeneous patient population both in terms of cognitive and noncognitive symptoms and in terms of etiology and prognosis. This provides a challenge when applying this construct in clinical practice. This paper presents the rationale and design of the TRACE-VCI study, which investigates the clinical features and prognosis of VCI in a memory clinic setting. The TRACE-VCI project is an observational, prospective cohort study of 861 consecutive memory clinic patients with possible VCI. Between 2009 and 2013, patients were recruited through the Amsterdam Dementia Cohort of the VU University Medical Centre (VUMC) (N=665) and the outpatient memory clinic and VCI cohort of the University Medical Centre Utrecht (UMCU) (N=196). We included all patients attending the clinics with magnetic resonance imaging (MRI) evidence of vascular brain injury. Patients with a primary etiology other than vascular brain injury or neurodegeneration were excluded. Patients underwent an extensive 1-day memory clinic evaluation including an interview, physical and neurological examination, assessment of biomarkers (including those for Alzheimer-type pathologies), extensive neuropsychological testing, and an MRI scan of the brain. For prognostic analyses, the composite primary outcome measure was defined as accelerated cognitive decline (change of clinical dementia rating ≥1 or institutionalization) or (recurrent) major vascular events or death over the course of 2 years. The mean age at baseline was 67.7 (SD 8.5) years and 46.3% of patients (399/861) were female. At baseline, the median Clinical Dementia Rating was 0.5 (interquartile range [IQR] 0.5-1.0) and the median Mini-Mental State Examination score was 25 (IQR 22-28). The clinical diagnosis at baseline was dementia in 52.4% of patients (451/861), mild cognitive impairment in 24.6% (212/861), and no objective cognitive impairment in the remaining 23.0% (198/861). The TRACE-VCI study represents a large cohort of well-characterized patients with VCI in a memory clinic setting. Data processing and collection for follow-up are currently being completed. The TRACE-VCI study will provide insight into the clinical features of memory clinic patients that meet VCI criteria and establish key prognostic factors for further cognitive decline and (recurrent) major vascular events.